← Home
🚀 Sign up Free for Company Insights & Valuation!
Sign up for free to get access to the best public company valuation and insights. Get started today and unlock the potential of your investments!
Sign up free
China Medical System
-9.57%
Pharma / Pharmaceuticals and Healthcare Services
At a Glance | Core Facts | Company Due Diligence | Industry Due Diligence | Competitors | Stock Swings | News | Income | Balance | Cash Flow | Growth | Enterprise | Ratios | Metrics | Dividends | Risks | SWOT | Porter's Five Forces | PEST | Score Positive | Clusters | Reports | WebOverview
China Medical System is a publicly traded pharmaceutical company based in China. It was founded in 1995 and is listed on both the Hong Kong Stock Exchange and the London Stock Exchange.
The company's main focus is on research, development, production, and sales of pharmaceutical products in China. It has a strong presence in the Chinese market, with partnerships and collaborations with both multinational and local pharmaceutical companies.
China Medical System is also involved in the distribution and marketing of imported drugs and medical devices in China. It has a diverse portfolio of products, including treatments for cardiovascular diseases, infectious diseases, and respiratory disorders.
In addition to its pharmaceutical business, the company also has a healthcare services division, which provides medical marketing and logistics services to hospitals, clinics, and other healthcare institutions in China.
The company places a strong emphasis on research and development, with a dedicated team of scientists working on developing new drugs and improving existing ones.
China Medical System is committed to ethical and responsible business practices, and has implemented strict quality control measures to ensure the safety and effectiveness of its products. It also actively engages in corporate social responsibility initiatives, including community healthcare programs and disaster relief efforts.
Overall, China Medical System is a reputable and established company in the Chinese pharmaceutical industry, with a strong track record of growth and innovation.
The company's main focus is on research, development, production, and sales of pharmaceutical products in China. It has a strong presence in the Chinese market, with partnerships and collaborations with both multinational and local pharmaceutical companies.
China Medical System is also involved in the distribution and marketing of imported drugs and medical devices in China. It has a diverse portfolio of products, including treatments for cardiovascular diseases, infectious diseases, and respiratory disorders.
In addition to its pharmaceutical business, the company also has a healthcare services division, which provides medical marketing and logistics services to hospitals, clinics, and other healthcare institutions in China.
The company places a strong emphasis on research and development, with a dedicated team of scientists working on developing new drugs and improving existing ones.
China Medical System is committed to ethical and responsible business practices, and has implemented strict quality control measures to ensure the safety and effectiveness of its products. It also actively engages in corporate social responsibility initiatives, including community healthcare programs and disaster relief efforts.
Overall, China Medical System is a reputable and established company in the Chinese pharmaceutical industry, with a strong track record of growth and innovation.
What is special about the company?
1. Leading pharmaceutical company in China: China Medical System (CMS) is one of the top pharmaceutical companies in China, with a strong market presence and a wide range of products.
2. Focus on innovation and growth: CMS has a strong focus on innovation and investing in new technologies and products. This has helped the company to grow rapidly and successfully enter new markets.
3. Strong distribution network: CMS has an extensive distribution network in China, with over 3,000 hospitals, 60,000 pharmacies, and 3,500 drugstores. This enables the company to reach a large customer base and effectively promote its products.
4. Diverse product portfolio: CMS has a diverse product portfolio, with a focus on prescription drugs and consumer health products. This has helped the company to maintain a stable revenue stream and mitigate risks.
5. Strategic partnerships: CMS has established strategic partnerships with international pharmaceutical companies, which has helped the company to expand its product offerings and enter new markets.
6. Strong financial performance: CMS has consistently delivered strong financial results, with steady revenue growth and high profitability. This has made the company a preferred choice for investors.
7. Focus on ethical business practices: CMS places a strong emphasis on ethical business practices and compliance. This has helped to build trust and credibility with stakeholders, including customers, investors, and regulatory bodies.
8. Commitment to social responsibility: CMS is committed to giving back to society and has initiated various social responsibility programs, including providing free medication to disadvantaged communities and supporting medical research and education.
9. Experienced management team: The company's leadership team has a wealth of experience in the pharmaceutical industry, with a strong track record of success. This has helped to guide the company towards sustainable growth and success.
10. Strong brand reputation: CMS has built a strong brand reputation in the Chinese market, known for its high-quality products, ethical business practices, and commitment to social responsibility. This has helped to create a loyal customer base and industry recognition.
2. Focus on innovation and growth: CMS has a strong focus on innovation and investing in new technologies and products. This has helped the company to grow rapidly and successfully enter new markets.
3. Strong distribution network: CMS has an extensive distribution network in China, with over 3,000 hospitals, 60,000 pharmacies, and 3,500 drugstores. This enables the company to reach a large customer base and effectively promote its products.
4. Diverse product portfolio: CMS has a diverse product portfolio, with a focus on prescription drugs and consumer health products. This has helped the company to maintain a stable revenue stream and mitigate risks.
5. Strategic partnerships: CMS has established strategic partnerships with international pharmaceutical companies, which has helped the company to expand its product offerings and enter new markets.
6. Strong financial performance: CMS has consistently delivered strong financial results, with steady revenue growth and high profitability. This has made the company a preferred choice for investors.
7. Focus on ethical business practices: CMS places a strong emphasis on ethical business practices and compliance. This has helped to build trust and credibility with stakeholders, including customers, investors, and regulatory bodies.
8. Commitment to social responsibility: CMS is committed to giving back to society and has initiated various social responsibility programs, including providing free medication to disadvantaged communities and supporting medical research and education.
9. Experienced management team: The company's leadership team has a wealth of experience in the pharmaceutical industry, with a strong track record of success. This has helped to guide the company towards sustainable growth and success.
10. Strong brand reputation: CMS has built a strong brand reputation in the Chinese market, known for its high-quality products, ethical business practices, and commitment to social responsibility. This has helped to create a loyal customer base and industry recognition.
What the company's business model?
China Medical System is a company that operates in the healthcare industry and primarily focuses on introducing and distributing innovative international pharmaceutical products to the Chinese market. The company's business model primarily involves three main activities:
1. Product licensing and distribution: China Medical System acquires the rights to market, sell, and distribute pharmaceutical products from international companies in the Chinese market. This is the core business of the company, and it generates the majority of its revenue.
2. Promotions and marketing: The company is responsible for promoting and marketing the products it distributes to healthcare professionals and end consumers. This includes conducting promotional activities, organizing medical conferences and seminars, and providing educational and training programs.
3. Drug development and investments: China Medical System also invests in the development of new drugs and medical technologies through partnerships and collaborations with international companies. This allows the company to expand its product portfolio and enter into new therapeutic areas.
Overall, China Medical System's business model is focused on importing and distributing high-quality medical products to meet the demand of the Chinese market, promoting and marketing these products, and investing in the development of new drugs and medical technologies to further strengthen its market position.
1. Product licensing and distribution: China Medical System acquires the rights to market, sell, and distribute pharmaceutical products from international companies in the Chinese market. This is the core business of the company, and it generates the majority of its revenue.
2. Promotions and marketing: The company is responsible for promoting and marketing the products it distributes to healthcare professionals and end consumers. This includes conducting promotional activities, organizing medical conferences and seminars, and providing educational and training programs.
3. Drug development and investments: China Medical System also invests in the development of new drugs and medical technologies through partnerships and collaborations with international companies. This allows the company to expand its product portfolio and enter into new therapeutic areas.
Overall, China Medical System's business model is focused on importing and distributing high-quality medical products to meet the demand of the Chinese market, promoting and marketing these products, and investing in the development of new drugs and medical technologies to further strengthen its market position.
Interesting facts about the company
1. China Medical System (CMS) is a Chinese-owned pharmaceutical company that focuses on the development, manufacture, and distribution of medicines and medical devices.
2. Founded in 1995, CMS has headquarters in Guangzhou, China and is listed on the Hong Kong Stock Exchange.
3. The company has a comprehensive product portfolio, including prescription drugs, OTC medicines, medical devices, and healthcare services.
4. CMS has partnerships and collaborations with both domestic and international companies, enabling them to access a wide range of therapeutic areas and market segments.
5. In 2019, CMS was ranked as the 44th largest pharmaceutical company in the world by revenue by Forbes.
6. CMS is committed to innovation and investing in research and development, with a focus on chronic diseases and rare diseases.
7. The company has a strong presence in China, with sales and distribution networks covering over 30 provinces, municipalities, and autonomous regions.
8. CMS has expanded internationally and has established subsidiaries in the United States, Europe, South Korea, and other countries, as well as distribution partnerships in over 30 countries and regions.
9. As part of its corporate social responsibility, CMS has initiated various programs to improve access to healthcare for underprivileged communities and support educational and medical research initiatives.
10. In 2020, CMS was ranked as the 12th most competitive listed pharmaceutical company in China by the Chinese Academy of Medical Sciences (CAMS) Research Center for Corporate Governance.
See Company Due Diligence:
2. Founded in 1995, CMS has headquarters in Guangzhou, China and is listed on the Hong Kong Stock Exchange.
3. The company has a comprehensive product portfolio, including prescription drugs, OTC medicines, medical devices, and healthcare services.
4. CMS has partnerships and collaborations with both domestic and international companies, enabling them to access a wide range of therapeutic areas and market segments.
5. In 2019, CMS was ranked as the 44th largest pharmaceutical company in the world by revenue by Forbes.
6. CMS is committed to innovation and investing in research and development, with a focus on chronic diseases and rare diseases.
7. The company has a strong presence in China, with sales and distribution networks covering over 30 provinces, municipalities, and autonomous regions.
8. CMS has expanded internationally and has established subsidiaries in the United States, Europe, South Korea, and other countries, as well as distribution partnerships in over 30 countries and regions.
9. As part of its corporate social responsibility, CMS has initiated various programs to improve access to healthcare for underprivileged communities and support educational and medical research initiatives.
10. In 2020, CMS was ranked as the 12th most competitive listed pharmaceutical company in China by the Chinese Academy of Medical Sciences (CAMS) Research Center for Corporate Governance.
See Company Due Diligence:
Wait! There's more — sign up for free or log in